Medpace Holdings

World Rank (Jan-05-2024)

1,782

Market Cap (Jan-05-2024)

9.093 Billion USD

World Rank (Jul-30-2023)

2,061

Market Cap (Jul-30-2023)

7.771 Billion USD

World Rank (Jan-07-2022)

2,575

Market Cap (Jan-07-2022)

6.757 Billion USD

World Rank (Jan-01-2021)

2,938

Market Cap (Jan-01-2021)

4.979 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 726

Headquarters Country

USA

Nasdaq / NYSE Code

MEDP

Market Cap (Mar-08-2026)

13.36

Employee Count

5,200

Employee Count as of Date

As on 2022

Headquarters City/State

Ohio

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

1,459 Million USD

Annual Operating Income in USD

278 Million USD

Annual Net Income in USD

245 Million USD

Annual Results for Period Ending

Dec-2022 ending year

Total Assets in USD

1,352 Million USD

Total Liabilities in USD

966 Million USD

Total Equity in USD

386 Million USD

Balance Sheet for Period Ending

Dec-2022 ending year

Business Sector

Health Care Diagnostics

Company Website

MEDPACE HOLDINGS INC

Yahoo

Yahoo @ Nasdaq

Company Profile

Medpace Holdings clinical research, therapeutic and specialty areas are autoimmune diseases, cardiovascular, endocrine and metabolic, hematology and oncology, infectious diseases and vaccines, nephrology, neuroscience, pediatrics, rare disease and orphan indications and advanced therapies. The headquarters is in USA.

Annual Results Summary